Patent · US Active

Analogs of xanomeline

US12269818B2 · kind B2 · utility

0Cited by
8References
42Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 16, 2024
Grant dateApr 8, 2025
Priority date—
Expiry dateFeb 16, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Disclosed herein are xanomeline analogs, as well as methods for making and using the analogs to, for example, treat neuropsychiatric disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.